Search results
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
FOX 23 News Albany· 23 hours agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to ...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
KIMT Mason City· 6 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoSome investors might view Moderna (NASDAQ: MRNA) as a shooting star that shined bright for a while then flamed out. In 2022, the biotech company...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 6 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 6 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 6 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the...
Simply Wall St. via Yahoo Finance· 2 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 3 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...